BioInsights - New horizons in cellular immunotherapy - spotlight

CELL & GENE THERAPY INSIGHTS

New horizons in cellular immunotherapy

August 2022
New horizons in cellular immunotherapy
Download PDF

Expert Insight

CAR T cell immunotherapy of epithelial ovarian cancer: past, present and a view of the horizon

CAR T cell immunotherapy of epithelial ovarian cancer: past, present and a view of the horizon

Jana Obajdin, John Maher
12 August 2022
Read

Interview

Advancing genome edited allogeneic cell therapies into the clinic

Advancing genome edited allogeneic cell therapies into the clinic

Steve Kanner
25 August 2022
Read
Ensuring commercial readiness in the cellular cancer immunotherapy space

Ensuring commercial readiness in the cellular cancer immunotherapy space

J Adams, M Korfin, R Simantov
15 August 2022
Read

Podcast

Working together to safely advance cell & gene therapies

Working together to safely advance cell & gene therapies

J Maher, A King, F Neethling et al.
11 September 2022
Listen

Expert Roundtable

Autologous versus allogeneic: the future of manufacturing and standardization in cell therapies

Autologous versus allogeneic: the future of manufacturing and standardization in cell therapies

R Pike, D Motlagh, P Hanley
4 October 2022
Read

FastFacts

Scalable production of lipid nanoparticles for effective gene delivery

Scalable production of lipid nanoparticles for effective gene delivery

Reka Geczy
11 October 2022
Read

Viewpoint

<em>In vivo</em> engineering of CAR T cell therapies

In vivo engineering of CAR T cell therapies

Haig Aghajanian
29 August 2022
Read
A journey in synthetic biology: using gene circuit technology in immuno-oncology

A journey in synthetic biology: using gene circuit technology in immuno-oncology

Timothy Lu, James Collins
24 August 2022
Read
The power of combining iPSC-derived NK cell therapy & NK-cell engager antibodies

The power of combining iPSC-derived NK cell therapy & NK-cell engager antibodies

Dr Wei Li, Dr Daniel Teper
21 July 2022
Read